▶ 調査レポート

世界の副腎白質ジストロフィー薬市場:専門的調査

• 英文タイトル:Global Adrenoleukodystrophy Drugs Market Professional Survey Report 2019

QYResearchが調査・発行した産業分析レポートです。世界の副腎白質ジストロフィー薬市場:専門的調査 / Global Adrenoleukodystrophy Drugs Market Professional Survey Report 2019 / QYR9ST14587資料のイメージです。• レポートコード:QYR9ST14587
• 出版社/出版日:QYResearch / 2019年9月10日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥518,000 (USD3,500)▷ お問い合わせ
  Enterprise License¥1,036,000 (USD7,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートは、副腎白質ジストロフィー薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ビオチン、DRX-065、DUOC-01、レンチD、MIN-102、OP-101、その他に、用途別には、子供、大人にセグメント区分し、副腎白質ジストロフィー薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・副腎白質ジストロフィー薬の世界市場概要
・副腎白質ジストロフィー薬の製造コスト構成分析
・副腎白質ジストロフィー薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・副腎白質ジストロフィー薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・副腎白質ジストロフィー薬のセグメント分析(種類別)
(ビオチン、DRX-065、DUOC-01、レンチD、MIN-102、OP-101、その他)
・副腎白質ジストロフィー薬のセグメント分析(用途別)
(子供、大人)
・副腎白質ジストロフィー薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Applied Genetic Technologies Corp、Bluebird Bio Inc、MedDay SA、Minoryx Therapeutics sl、Pfizer Inc、ReceptoPharm Inc、SOM Biotech SL、Viking Therapeutics Inc)
・副腎白質ジストロフィー薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...

The global Adrenoleukodystrophy Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Adrenoleukodystrophy Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Adrenoleukodystrophy Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Adrenoleukodystrophy Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Adrenoleukodystrophy Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Applied Genetic Technologies Corp
Bluebird Bio Inc
MedDay SA
Minoryx Therapeutics sl
Pfizer Inc
ReceptoPharm Inc
SOM Biotech SL
Viking Therapeutics Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Biotin
DRX-065
DUOC-01
Lenti-D
MIN-102
OP-101
Others

Segment by Application
Children
Adult

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Adrenoleukodystrophy Drugs
1.1 Definition of Adrenoleukodystrophy Drugs
1.2 Adrenoleukodystrophy Drugs Segment by Type
1.2.1 Global Adrenoleukodystrophy Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Biotin
1.2.3 DRX-065
1.2.4 DUOC-01
1.2.5 Lenti-D
1.2.6 MIN-102
1.2.7 OP-101
1.2.8 Others
1.3 Adrenoleukodystrophy Drugs Segment by Applications
1.3.1 Global Adrenoleukodystrophy Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Children
1.3.3 Adult
1.4 Global Adrenoleukodystrophy Drugs Overall Market
1.4.1 Global Adrenoleukodystrophy Drugs Revenue (2014-2025)
1.4.2 Global Adrenoleukodystrophy Drugs Production (2014-2025)
1.4.3 North America Adrenoleukodystrophy Drugs Status and Prospect (2014-2025)
1.4.4 Europe Adrenoleukodystrophy Drugs Status and Prospect (2014-2025)
1.4.5 China Adrenoleukodystrophy Drugs Status and Prospect (2014-2025)
1.4.6 Japan Adrenoleukodystrophy Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Adrenoleukodystrophy Drugs Status and Prospect (2014-2025)
1.4.8 India Adrenoleukodystrophy Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Adrenoleukodystrophy Drugs
2.3 Manufacturing Process Analysis of Adrenoleukodystrophy Drugs
2.4 Industry Chain Structure of Adrenoleukodystrophy Drugs

3 Development and Manufacturing Plants Analysis of Adrenoleukodystrophy Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Adrenoleukodystrophy Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Adrenoleukodystrophy Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Adrenoleukodystrophy Drugs Production and Capacity Analysis
4.2 Adrenoleukodystrophy Drugs Revenue Analysis
4.3 Adrenoleukodystrophy Drugs Price Analysis
4.4 Market Concentration Degree

5 Adrenoleukodystrophy Drugs Regional Market Analysis
5.1 Adrenoleukodystrophy Drugs Production by Regions
5.1.1 Global Adrenoleukodystrophy Drugs Production by Regions
5.1.2 Global Adrenoleukodystrophy Drugs Revenue by Regions
5.2 Adrenoleukodystrophy Drugs Consumption by Regions
5.3 North America Adrenoleukodystrophy Drugs Market Analysis
5.3.1 North America Adrenoleukodystrophy Drugs Production
5.3.2 North America Adrenoleukodystrophy Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Adrenoleukodystrophy Drugs Import and Export
5.4 Europe Adrenoleukodystrophy Drugs Market Analysis
5.4.1 Europe Adrenoleukodystrophy Drugs Production
5.4.2 Europe Adrenoleukodystrophy Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Adrenoleukodystrophy Drugs Import and Export
5.5 China Adrenoleukodystrophy Drugs Market Analysis
5.5.1 China Adrenoleukodystrophy Drugs Production
5.5.2 China Adrenoleukodystrophy Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Adrenoleukodystrophy Drugs Import and Export
5.6 Japan Adrenoleukodystrophy Drugs Market Analysis
5.6.1 Japan Adrenoleukodystrophy Drugs Production
5.6.2 Japan Adrenoleukodystrophy Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Adrenoleukodystrophy Drugs Import and Export
5.7 Southeast Asia Adrenoleukodystrophy Drugs Market Analysis
5.7.1 Southeast Asia Adrenoleukodystrophy Drugs Production
5.7.2 Southeast Asia Adrenoleukodystrophy Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Adrenoleukodystrophy Drugs Import and Export
5.8 India Adrenoleukodystrophy Drugs Market Analysis
5.8.1 India Adrenoleukodystrophy Drugs Production
5.8.2 India Adrenoleukodystrophy Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Adrenoleukodystrophy Drugs Import and Export

6 Adrenoleukodystrophy Drugs Segment Market Analysis (by Type)
6.1 Global Adrenoleukodystrophy Drugs Production by Type
6.2 Global Adrenoleukodystrophy Drugs Revenue by Type
6.3 Adrenoleukodystrophy Drugs Price by Type

7 Adrenoleukodystrophy Drugs Segment Market Analysis (by Application)
7.1 Global Adrenoleukodystrophy Drugs Consumption by Application
7.2 Global Adrenoleukodystrophy Drugs Consumption Market Share by Application (2014-2019)

8 Adrenoleukodystrophy Drugs Major Manufacturers Analysis
8.1 Applied Genetic Technologies Corp
8.1.1 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production Sites and Area Served
8.1.2 Applied Genetic Technologies Corp Product Introduction, Application and Specification
8.1.3 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bluebird Bio Inc
8.2.1 Bluebird Bio Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
8.2.2 Bluebird Bio Inc Product Introduction, Application and Specification
8.2.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 MedDay SA
8.3.1 MedDay SA Adrenoleukodystrophy Drugs Production Sites and Area Served
8.3.2 MedDay SA Product Introduction, Application and Specification
8.3.3 MedDay SA Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Minoryx Therapeutics sl
8.4.1 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production Sites and Area Served
8.4.2 Minoryx Therapeutics sl Product Introduction, Application and Specification
8.4.3 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Pfizer Inc
8.5.1 Pfizer Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
8.5.2 Pfizer Inc Product Introduction, Application and Specification
8.5.3 Pfizer Inc Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 ReceptoPharm Inc
8.6.1 ReceptoPharm Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
8.6.2 ReceptoPharm Inc Product Introduction, Application and Specification
8.6.3 ReceptoPharm Inc Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 SOM Biotech SL
8.7.1 SOM Biotech SL Adrenoleukodystrophy Drugs Production Sites and Area Served
8.7.2 SOM Biotech SL Product Introduction, Application and Specification
8.7.3 SOM Biotech SL Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Viking Therapeutics Inc
8.8.1 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
8.8.2 Viking Therapeutics Inc Product Introduction, Application and Specification
8.8.3 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Adrenoleukodystrophy Drugs Market
9.1 Global Adrenoleukodystrophy Drugs Market Trend Analysis
9.1.1 Global Adrenoleukodystrophy Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Adrenoleukodystrophy Drugs Regional Market Trend
9.2.1 North America Adrenoleukodystrophy Drugs Forecast 2019-2025
9.2.2 Europe Adrenoleukodystrophy Drugs Forecast 2019-2025
9.2.3 China Adrenoleukodystrophy Drugs Forecast 2019-2025
9.2.4 Japan Adrenoleukodystrophy Drugs Forecast 2019-2025
9.2.5 Southeast Asia Adrenoleukodystrophy Drugs Forecast 2019-2025
9.2.6 India Adrenoleukodystrophy Drugs Forecast 2019-2025
9.3 Adrenoleukodystrophy Drugs Market Trend (Product Type)
9.4 Adrenoleukodystrophy Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Adrenoleukodystrophy Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Adrenoleukodystrophy Drugs
Table Global Adrenoleukodystrophy Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Adrenoleukodystrophy Drugs Production Market Share by Types in 2018
Figure Biotin Product Picture
Figure DRX-065 Product Picture
Figure DUOC-01 Product Picture
Figure Lenti-D Product Picture
Figure MIN-102 Product Picture
Figure OP-101 Product Picture
Figure Others Product Picture
Table Global Adrenoleukodystrophy Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Adrenoleukodystrophy Drugs Consumption Market Share by Applications in 2018
Figure Children
Figure Adult
Figure Global Adrenoleukodystrophy Drugs Revenue (Million USD) (2014-2025)
Figure Global Adrenoleukodystrophy Drugs Production (K Pcs) (2014-2025)
Figure North America Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025)
Figure Europe Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025)
Figure China Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025)
Figure Japan Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025)
Figure India Adrenoleukodystrophy Drugs Market Size (Million USD) (2014-2025)
Table Adrenoleukodystrophy Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Adrenoleukodystrophy Drugs in 2018
Figure Manufacturing Process Analysis of Adrenoleukodystrophy Drugs
Figure Industry Chain Structure of Adrenoleukodystrophy Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Adrenoleukodystrophy Drugs Manufacturing Plants Distribution
Table Adrenoleukodystrophy Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Adrenoleukodystrophy Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Adrenoleukodystrophy Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Adrenoleukodystrophy Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Adrenoleukodystrophy Drugs Production Share by Manufacturers in 2018
Table Adrenoleukodystrophy Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Adrenoleukodystrophy Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Adrenoleukodystrophy Drugs Revenue Share by Manufacturers in 2018
Table Adrenoleukodystrophy Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Adrenoleukodystrophy Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Adrenoleukodystrophy Drugs Production Market Share by Regions 2014-2019
Figure Global Adrenoleukodystrophy Drugs Production Market Share by Regions in 2018
Table Global Adrenoleukodystrophy Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Adrenoleukodystrophy Drugs Revenue Market Share by Regions 2014-2019
Figure Global Adrenoleukodystrophy Drugs Revenue Market Share by Regions in 2018
Table Global Adrenoleukodystrophy Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Adrenoleukodystrophy Drugs Consumption Market Share by Regions 2014-2019
Figure North America Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs)
Figure China Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs)
Figure India Adrenoleukodystrophy Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Adrenoleukodystrophy Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Adrenoleukodystrophy Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Adrenoleukodystrophy Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Adrenoleukodystrophy Drugs Market Share by Application (2014-2019)
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production Sites and Area Served
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production Market Share (2014-2019)
Figure Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019)
Table Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Main Business and Markets Served
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Production Market Share (2014-2019)
Figure Bluebird Bio Inc Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019)
Table Bluebird Bio Inc Adrenoleukodystrophy Drugs Main Business and Markets Served
Table MedDay SA Adrenoleukodystrophy Drugs Production Sites and Area Served
Table MedDay SA Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
Table MedDay SA Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table MedDay SA Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
Table MedDay SA Adrenoleukodystrophy Drugs Production Market Share (2014-2019)
Figure MedDay SA Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019)
Table MedDay SA Adrenoleukodystrophy Drugs Main Business and Markets Served
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production Sites and Area Served
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production Market Share (2014-2019)
Figure Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019)
Table Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Main Business and Markets Served
Table Pfizer Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
Table Pfizer Inc Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
Table Pfizer Inc Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Inc Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
Table Pfizer Inc Adrenoleukodystrophy Drugs Production Market Share (2014-2019)
Figure Pfizer Inc Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019)
Table Pfizer Inc Adrenoleukodystrophy Drugs Main Business and Markets Served
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Production Market Share (2014-2019)
Figure ReceptoPharm Inc Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019)
Table ReceptoPharm Inc Adrenoleukodystrophy Drugs Main Business and Markets Served
Table SOM Biotech SL Adrenoleukodystrophy Drugs Production Sites and Area Served
Table SOM Biotech SL Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
Table SOM Biotech SL Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table SOM Biotech SL Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
Table SOM Biotech SL Adrenoleukodystrophy Drugs Production Market Share (2014-2019)
Figure SOM Biotech SL Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019)
Table SOM Biotech SL Adrenoleukodystrophy Drugs Main Business and Markets Served
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production Market Share (2014-2019)
Figure Viking Therapeutics Inc Adrenoleukodystrophy Drugs Revenue Market Share (2014-2019)
Table Viking Therapeutics Inc Adrenoleukodystrophy Drugs Main Business and Markets Served
Figure Global Adrenoleukodystrophy Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Adrenoleukodystrophy Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Adrenoleukodystrophy Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Adrenoleukodystrophy Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Adrenoleukodystrophy Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Adrenoleukodystrophy Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Adrenoleukodystrophy Drugs by Application (2019-2025)
Table Adrenoleukodystrophy Drugs Distributors List
Table Adrenoleukodystrophy Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources